|
|
CD45 Antibody, anti-non-human primate, PE-Vio 770, REAfinity 130-117-195 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
REA1023 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD45 Antibody, anti-non-human primate, PE-Vio 770, REAfinity 130-117-286 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
REA1023 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD44 Antibody, anti-mouse, PE-Vio 770 130-102-377 |
FCM
IF
IHC
Other
|
NHPr
Ms
|
PE-Vio 770
|
IM7.8.1 |
30 µg in 1 mL |
¥20,100 |
|
|
|
CD44 Antibody, anti-mouse, PE-Vio 770 130-102-904 |
FCM
IF
IHC
Other
|
NHPr
Ms
|
PE-Vio 770
|
IM7.8.1 |
9 µg in 300 µL |
¥9,500 |
|
|
|
CD11b Antibody, anti-mouse, PE-Vio 770, REAfinity 130-113-808 |
FCM
IF
IHC
Other
|
Hu
NHPr
Ms
|
PE-Vio 770
|
REA592 |
30 µg in 200 µL |
¥20,100 |
|
|
|
CD11b Antibody, anti-mouse, PE-Vio 770, REAfinity 130-113-246 |
FCM
IF
IHC
Other
|
Hu
NHPr
Ms
|
PE-Vio 770
|
REA592 |
150 µg in 1 mL |
¥58,300 |
|
|
|
CD45RO Antibody, anti-human, PE-Vio 770 130-113-551 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 770
|
UCHL1 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD32 Antibody, anti-human, PE-Vio 770, REAfinity 130-116-722 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 770
|
REA997 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD11a Antibody, anti-human, PE-Vio 770, REAfinity 130-127-972 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 770
|
REA378 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD271 (LNGFR) Antibody, anti-human, PE-Vio 770 130-113-984 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
ME20.4-1.H4 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
HLA-DR Antibody, anti-human, PE-Vio 770 130-113-403 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 770
|
AC122 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD49d Antibody, anti-human, PE-Vio 770, REAfinity 130-125-527 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
REA545 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD14 Antibody, anti-human, PE-Vio 770 130-113-711 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
TÜK4 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD271 (LNGFR) Antibody, anti-human, PE-Vio 770, REAfinity 130-112-603 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
REA844 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD271 (LNGFR) Antibody, anti-human, PE-Vio 770 130-113-422 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
ME20.4-1.H4 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD32 Antibody, anti-human, PE-Vio 770 130-097-506 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 770
|
2E1 |
100 テスト(1 mL) |
¥65,700 |
|
|
|
CD14 Antibody, anti-human, PE-Vio 770 130-113-149 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
TÜK4 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD271 (LNGFR) Antibody, anti-human, PE-Vio 770, REAfinity 130-112-792 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
REA844 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD32 Antibody, anti-human, PE-Vio 770, REAfinity 130-116-601 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 770
|
REA997 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD45RO Antibody, anti-human, PE-Vio 770 130-114-077 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 770
|
UCHL1 |
30 テスト(60 µL) |
¥28,600 |
|